Problems › We Have Too Many Products › B2B SaaS
Each added module or tier spreads sales, onboarding and support effort across more SKUs, so the core ARR ends up funding capacity that never reaches the same payback. B2B SaaS companies carry a specific bind here — growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics. Until that is priced, net revenue retention will keep moving for reasons nobody can attribute, and the debate about contribution by SKU will stay a matter of opinion.
Each added module or tier spreads sales, onboarding and support effort across more SKUs, so the core ARR ends up funding capacity that never reaches the same payback. B2B SaaS companies carry a specific bind here — growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics. Until that is priced, net revenue retention will keep moving for reasons nobody can attribute, and the debate about contribution by SKU will stay a matter of opinion.
New modules and service tiers keep getting added to win specific deals or match competitors, yet nothing is retired. The result appears in diluted ACV concentration, longer CAC payback on the main offering, and higher gross-margin leakage from duplicated support and engineering time.
The segments with strong NRR and fast payback carry the overhead of the weaker ones through shared resources, which is why overall net revenue retention falls even when the tail lines show positive contribution in isolation.
Rank offerings by ACV and gross margin relative to the CAC and support burden each creates, then keep only those required by strategic accounts or that enable measurable land-and-expand motion.
These three together are the signature. One on its own usually points somewhere else.
✓ Most ARR concentrates in a few modules while net revenue retention is pulled down by the rest
✓ No modules or pricing tiers have been removed in several years
✓ Engineering and support load grows faster than new ARR bookings
The move that usually makes it worse. Dropping the lowest-ACV items first, which often removes the cheap-to-serve lines and leaves the ones that quietly consume the most CAC payback capacity.
It is for you if you run or finance a B2B SaaS company and a minority of lines produces the large majority of revenue. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a B2B SaaS company. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is TechNova Solutions, a sample company profile used for testing rather than a customer — $45M ARR, 280 engineers.
Excerpt from a real Percision run · Customer Value Architecture · sample company profile
The move. Turn the 11-week implementation backlog into 50 reusable modules that lift services gross margin from 41 % to 55 % while preserving 23 % win rate.
| Investment required | $3.0-4.2 M total over 36 months |
| Expected return | Base case 3.8× cash-on-cash within 36 months |
| Revenue, year 1 | $47.8-49.2 M ARR |
| Revenue, year 2 | $51.5-54.0 M ARR |
| Revenue, year 3 | $56.0-60.0 M ARR |
| Exit criteria | Strategy abandoned if, by Month 12, template-able rule rate remains below 40 % OR if NRR of pilot cohort falls below 85 %; capital reallocated to Segment 2 analytics bolt-on. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Matrix Strategy, one of 29 engagements the platform runs. For B2B SaaS companies it works through net revenue retention, CAC payback, ACV by segment and gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Contribution per unit of the binding constraint, then a check on strategic dependencies. Revenue rank alone gets this wrong in both directions.
Some will, and the analysis should price that before the decision rather than after. Usually the revenue at risk is smaller than the complexity cost being removed, but it should be a finding rather than an assumption.
It is rarely tracked, which is why it grows. A workable proxy is the trend in operating cost per unit of volume; when that rises while volume rises, complexity is the usual explanation.
Materially, yes. Growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are net revenue retention, CAC payback, ACV by segment, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on net revenue retention and CAC payback. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית